Red Spruce Capital, LLC Merck & Co., Inc. Transaction History

Red Spruce Capital, LLC

  • $218 Million
  • Q4 2024

A detailed history of Red Spruce Capital, LLC transactions in Merck & Co., Inc. stock. As of the latest transaction made, Red Spruce Capital, LLC holds 42,739 shares of MRK stock, worth $4.08 Million. This represents 1.95% of its overall portfolio holdings.

Number of Shares
42,739
Previous 39,440 8.36%
Holding current value
$4.08 Million
Previous $4.48 Million 5.07%
% of portfolio
1.95%
Previous 2.11%

Shares

21 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Jan 17, 2025
BUY
$96.31 - $114.76 $317,726 - $378,593
3,299 Added 8.36%
42,739 $4.25 Million
Q3 2024

Oct 04, 2024
SELL
$111.15 - $128.97 $17,672 - $20,506
-159 Reduced 0.4%
39,440 $4.48 Million
Q2 2024

Jul 02, 2024
BUY
$123.8 - $132.96 $54,224 - $58,236
438 Added 1.12%
39,599 $4.9 Million
Q1 2024

Apr 10, 2024
BUY
$113.24 - $131.95 $15,740 - $18,341
139 Added 0.36%
39,161 $5.17 Million
Q4 2023

Jan 05, 2024
BUY
$100.18 - $109.02 $62,211 - $67,701
621 Added 1.62%
39,022 $4.25 Million
Q3 2023

Oct 03, 2023
BUY
$102.95 - $114.33 $1,647 - $1,829
16 Added 0.04%
38,401 $3.95 Million
Q2 2023

Jul 05, 2023
SELL
$108.61 - $118.38 $1.51 Million - $1.64 Million
-13,875 Reduced 26.55%
38,385 $4.43 Million
Q1 2023

Apr 06, 2023
BUY
$102.94 - $114.86 $87,190 - $97,286
847 Added 1.65%
52,260 $5.56 Million
Q4 2022

Jan 03, 2023
BUY
$87.44 - $112.11 $72,750 - $93,275
832 Added 1.64%
51,413 $0
Q3 2022

Oct 03, 2022
SELL
$84.53 - $94.96 $238,036 - $267,407
-2,816 Reduced 5.27%
50,581 $4.36 Million
Q2 2022

Jul 05, 2022
SELL
$83.49 - $94.64 $31,809 - $36,057
-381 Reduced 0.71%
53,397 $4.87 Million
Q1 2022

Apr 05, 2022
BUY
$73.51 - $82.4 $146,358 - $164,058
1,991 Added 3.84%
53,778 $4.41 Million
Q4 2021

Jan 03, 2022
BUY
$72.28 - $90.54 $173,110 - $216,843
2,395 Added 4.85%
51,787 $3.97 Million
Q3 2021

Oct 04, 2021
BUY
$71.68 - $78.83 $263,137 - $289,384
3,671 Added 8.03%
49,392 $3.71 Million
Q2 2021

Jul 06, 2021
BUY
$70.31 - $77.77 $130,565 - $144,418
1,857 Added 4.23%
45,721 $3.56 Million
Q1 2021

Apr 01, 2021
BUY
$68.86 - $81.11 $313,519 - $369,293
4,553 Added 11.58%
43,864 $3.38 Million
Q4 2020

Jan 04, 2021
BUY
$71.77 - $79.65 $51,602 - $57,268
719 Added 1.86%
39,311 $3.22 Million
Q3 2020

Oct 02, 2020
SELL
$73.18 - $82.95 $10,025 - $11,364
-137 Reduced 0.35%
38,592 $3.2 Million
Q2 2020

Jul 02, 2020
BUY
$70.42 - $80.13 $1.49 Million - $1.69 Million
21,117 Added 119.9%
38,729 $3 Million
Q1 2020

Apr 06, 2020
BUY
$63.36 - $87.82 $17,740 - $24,589
280 Added 1.62%
17,612 $1.36 Million
Q4 2019

Jan 16, 2020
BUY
$77.58 - $87.54 $1.34 Million - $1.52 Million
17,332 New
17,332 $1.58 Million

Others Institutions Holding MRK

# of Institutions
3,815
Shares Held
1.87B
Call Options Held
15.6M
Put Options Held
13.7M
View Full List

About Merck & Co., Inc.

MRK Quotes by TradingView
  • Ticker MRK
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,533,280,000
  • Market Cap $242B
  • Description
  • Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, ...
More about MRK
Track This Portfolio

Track Red Spruce Capital, LLC Portfolio

Follow Red Spruce Capital, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Red Spruce Capital, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Red Spruce Capital, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email